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Treatment of HIV 
nephropathy  
with HAART
The epidemic of HIV sweeping across 
Africa is one of the major public-health 
challenges of modern times. Dealing 
with this scourge requires a commit-
ment on the part of governments and 
nongovernmental organizations, which 
have slowly been developing coping 
strategies, with varying success. Now, 
Peters et al. present a study in which 
they tracked the prevalence and treat-
ment of HIV nephropathy in Uganda in 
a home-care treatment network. They 
found that HIV nephropathy was quite 
common. Treatment with highly active 
antiretroviral therapy (HAART) not 
only improved the clinical outcomes 
of AIDS patients but also improved 
their glomerular filtration rates. These 
findings demonstrate that a treat-
ment thought to be suitable only in 
the developed world, where advanced 
public-health systems include follow-
up and management of complex HIV-
related diseases, is readily transferable 
to Africa. This result should energize 
both governmental and other bodies 
that are attempting to manage HIV and 
its related diseases. See page 925.
IL-6 and extrarenal 
injury induced by  
renal ischemia
Patients with acute kidney injury fre-
quently have pulmonary complications. 
Following ischemic injury, circulating 
factors perhaps produced by the kidney 
might induce organ damage at a distance 
from the kidney. In a new study, Klein 
et al. induced ischemic reperfusion 
injury in mice and found extensive 
lung neutrophil infiltration and capil-
lary leak shortly after ischemia of the 
kidney. However, these pathological 
findings were reduced when ischemia 
was induced in interleukin-6 (IL-6)-
deficient mice. Wild-type mice, treated 
with an IL-6-inactivating antibody, had 
decreased lung infiltration by leukocytes. 
These studies demonstrate the role 
of IL-6 as a critical mediator of extra-
renal injury induced by renal ischemia. 
See page 901. 
Progression  
of renal disease
Perhaps the most critical area of study 
in nephrology today is the progression 
of renal disease. A significant number 
of studies in humans and animals have 
shown that renal failure begins with an 
immunological or toxic insult, which 
acts as a trigger to initiate a cascade 
of events that lead inexorably to renal 
failure. Since the demonstration of this 
fact, many studies have attempted to 
examine the mechanisms by which pro-
gression occurs. In this issue, we exam-
ine this topic in a series of Reviews. 
Detlef Schlondorff, the Associate Editor 
responsible for the series, has written 
a comprehensive summary of the field 
(see page 860). Then, two papers, one 
by Fine and Norman (see page 867) 
and one by Ronco and Chatziantoniou 
(see page 873), discuss the mechanisms 
identified so far. In a subsequent issue 
we will present three additional papers 
that explore disease progression.
